Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 7, 2021; 27(33): 5610-5621
Published online Sep 7, 2021. doi: 10.3748/wjg.v27.i33.5610
Published online Sep 7, 2021. doi: 10.3748/wjg.v27.i33.5610
Characteristics | PNI+ (n = 144) | PNI- (n = 159) | P value | The training set(n = 242) | The validation set(n = 61) | P value |
Age (mean ± SD, yr) | 58.9 ± 11.8 | 58.9 ± 11.7 | 0.952 | 58.4 ± 11.9 | 60.8 ± 10.2 | 0.162 |
Sex (male/female) | 77/67 | 93/66 | 0.379 | 140/102 | 30/31 | 0.223 |
Volume (cm3) | 19.7 | 20.8 | 0.132 | 20.1 | 20.8 | 0.847 |
Location1 | 0.075 | 0.045 | ||||
Middle-low | 101 | 96 | 164 | 33 | ||
High | 43 | 63 | 78 | 28 | ||
cT stage (T1-2/T3/T4) | 25/98/21 | 57/90/12 | < 0.001 | 61/156/25 | 21/32/8 | 0.222 |
cN stage (N0/N1/N2) | 31/52/61 | 75/59/25 | < 0.001 | 89/84/69 | 17/27/17 | 0.313 |
Neoadjuvant therapy (+/-) | 25/119 | 37/122 | 0.203 | 51/191 | 11/50 | 0.599 |
CEA (+/-) (positive ≥ 5 ng/mL) | 77/67 | 56/103 | 0.001 | 107/135 | 26/35 | 0.823 |
CA19-9 (+/-) (positive ≥ 30 U/mL) | 43/101 | 35/124 | 0.119 | 64/178 | 14/47 | 0.577 |
CA125 (+/-) (positive ≥ 24 U/mL) | 20/124 | 15/144 | 0.226 | 20/222 | 3/58 | 0.378 |
pT stage (T1/T2/T3/T4) | 0/15/117/12 | 8/44/95/12 | < 0.001 | 6/48/171/17 | 2/11/41/7 | 0.584 |
pN stage (0/N1/N2) | 29/74/41 | 81/56/22 | < 0.001 | 88/101/53 | 22/29/10 | 0.579 |
Stage (Ⅰ/Ⅱ/Ⅲ) | 10/28/115 | 38/43/78 | < 0.001 | 40/48/154 | 8/14/39 | 0.731 |
Histologic grade (G1/G2/G3) | 1/105/38 | 2/133/24 | 0.014 | 2/189/51 | 1/49/11 | 0.523 |
Rad-score | 0.60 ± 0.19 | 0.40 ± 0.20 | < 0.001 | 0.50±0.21 | 0.49 ± 0.23 | 0.805 |
- Citation: Li M, Jin YM, Zhang YC, Zhao YL, Huang CC, Liu SM, Song B. Radiomics for predicting perineural invasion status in rectal cancer. World J Gastroenterol 2021; 27(33): 5610-5621
- URL: https://www.wjgnet.com/1007-9327/full/v27/i33/5610.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i33.5610